📚 Pharmacology Curriculum

Comprehensive guide to pharmacological principles and drug therapeutics

❓ Quiz 🔬 Exercises 🏠 Home

1Introduction to Pharmacology

Definition and Scope

Pharmacology is the science that studies how drugs interact with biological systems and the body's response to drug administration.

Key Disciplines:
  • Pharmacodynamics: What the drug does to the body - mechanism of action and effects
  • Pharmacokinetics: What the body does to the drug - absorption, distribution, metabolism, excretion
  • Toxicology: Study of poisonous effects and adverse reactions
  • Pharmacogenomics: How genetics affects drug response

Historical Development

Modern pharmacology emerged in the 19th century with the development of synthetic drugs. Understanding of drug action has evolved from empirical observation to molecular mechanisms based on receptor theory and signal transduction.

✓ Key Points

  • Pharmacology bridges chemistry, biology, and clinical medicine
  • Drug development requires understanding of both beneficial and adverse effects
  • Rational drug design is based on molecular and cellular mechanisms

2Pharmacokinetics: Drug Movement in the Body

ADME Process

Understanding how the body processes drugs is essential for determining dosing regimens and predicting drug interactions.

Process Description Key Factors
Absorption Movement of drug from administration site into systemic circulation Route, pH, blood flow, molecular size
Distribution Movement of drug throughout body tissues and fluids Lipophilicity, protein binding, blood-brain barrier
Metabolism Chemical modification of drug by liver and other tissues CYP450 enzymes, phase I-II reactions, genetics
Excretion Removal of drug and metabolites from body Renal clearance, hepatic excretion, biliary elimination

Drug Absorption

Routes of Administration:

  • Oral (PO): Most common, variable absorption, first-pass metabolism
  • Intravenous (IV): Direct entry to bloodstream, 100% bioavailability
  • Intramuscular (IM): Depot effect, slower than IV
  • Subcutaneous (SC): Slower absorption than IM
  • Transdermal: Prolonged effect, bypasses first-pass metabolism
  • Inhalation: Rapid onset, large surface area

Example: Bioavailability

Oral drug absorption can be significantly reduced by first-pass metabolism in the liver. For example, nitroglycerin is poorly absorbed orally but effective sublingually because it bypasses hepatic metabolism when absorbed directly into venous circulation.

Drug Distribution

The volume of distribution (Vd) describes how widely a drug spreads throughout body tissues relative to plasma.

Volume of Distribution (Vd) = Dose / Initial Concentration

Factors affecting distribution include protein binding, lipid solubility, and the ability to cross biological barriers such as the blood-brain barrier.

✓ Key Points

  • Bioavailability varies with route of administration
  • Protein binding affects free (active) drug concentration
  • Distribution to tissues creates drug depots and prolonged effects

3Pharmacodynamics: Drug Action and Effects

Receptor Theory

Most drugs act by binding to specific receptors (proteins) on cells, triggering a cascade of cellular events that produce therapeutic or adverse effects.

Types of Receptors:
  • G-Protein Coupled Receptors (GPCR): Most common, 7 transmembrane domains
  • Ion Channel Receptors: Direct control of ion flow
  • Enzyme-linked Receptors: Activate intracellular enzymes
  • Nuclear Receptors: Modify gene expression

Agonists vs. Antagonists

Agonists

Bind to receptors and activate them, producing a biological response. Full agonists produce maximum effect; partial agonists produce submaximal effects.

Antagonists

Bind to receptors without activating them, blocking the action of endogenous substances or agonist drugs. Competitive antagonists can be overcome by increasing agonist concentration; non-competitive antagonists provide irreversible blockade.

Dose-Response Relationship

The relationship between drug dose and intensity of therapeutic effect is fundamental to pharmacology.

Important Concepts:

Potency: Amount of drug needed to produce a given effect (ED50)

Efficacy: Maximum therapeutic effect a drug can produce at any dose

Therapeutic Index: Ratio of toxic dose to therapeutic dose (TD50/ED50) - higher values indicate greater safety

✓ Key Points

  • Receptor specificity determines drug selectivity and side effects
  • Dose-response curves show the relationship between drug amount and effect
  • Individual variability in drug response depends on genetics, age, and disease state

4Major Drug Classes and Mechanisms

Cardiovascular Drugs

Class Examples Mechanism
ACE Inhibitors Lisinopril, Enalapril Block angiotensin II formation, reduce blood pressure
Beta-Blockers Metoprolol, Propranolol Block β-adrenergic receptors, decrease heart rate and contractility
Statins Atorvastatin, Simvastatin Inhibit HMG-CoA reductase, reduce cholesterol synthesis
Diuretics Furosemide, Hydrochlorothiazide Increase urine production, reduce blood volume and pressure

Central Nervous System Drugs

Class Examples Therapeutic Use
SSRIs Sertraline, Paroxetine Depression, anxiety, OCD
Benzodiazepines Diazepam, Lorazepam Anxiety, seizures, muscle relaxation
Antipsychotics Haloperidol, Risperidone Schizophrenia, bipolar disorder
Analgesics Morphine, Ibuprofen Pain relief - opioid and non-opioid

Antimicrobial Drugs

Antibiotics

  • Beta-lactams: Penicillins and cephalosporins - inhibit bacterial cell wall synthesis
  • Aminoglycosides: Inhibit bacterial protein synthesis
  • Fluoroquinolones: Inhibit DNA gyrase and topoisomerase
  • Macrolides: Inhibit protein synthesis by binding to ribosome

Antivirals

  • Antiretrovirals: Reverse transcriptase inhibitors, protease inhibitors for HIV
  • Antiherpes: Acyclovir, inhibits viral DNA polymerase
  • Neuraminidase inhibitors: Oseltamivir for influenza

✓ Key Points

  • Drug classes are organized by therapeutic use or mechanism of action
  • Within a class, drugs may have different potency, selectivity, and side effect profiles
  • Understanding mechanisms helps predict effects and interactions

5Adverse Drug Reactions and Drug Interactions

Types of Adverse Reactions

Type Mechanism Examples
Type A (Augmented) Dose-dependent, expected pharmacological extension Hypoglycemia from insulin overdose
Type B (Bizarre) Idiosyncratic, not predictable from pharmacology Drug allergy, hemolytic anemia
Type C (Chronic) Time and dose-dependent toxicity Corticosteroid osteoporosis, tetracycline staining
Type D (Delayed) Long latency period Carcinogenesis, teratogenesis

Drug Interactions

Pharmacokinetic Interactions

  • Enzyme Induction: One drug increases metabolism of another (decreased effect)
  • Enzyme Inhibition: One drug decreases metabolism of another (increased effect)
  • Protein Binding Displacement: Compete for plasma protein binding sites
  • Renal Interactions: Compete for renal excretion or filtration

Pharmacodynamic Interactions

  • Synergy: Combined effect greater than sum of individual effects
  • Antagonism: One drug reduces effect of another
  • Additive Effects: Combined effect equals sum of individual effects

Clinical Significance:

NSAIDs can reduce the effectiveness of ACE inhibitors by inhibiting prostaglandin-mediated renal vasodilation. NSAIDs also increase risk of hyperkalemia when combined with ACE inhibitors.

✓ Key Points

  • Adverse reactions can be classified by mechanism and timing
  • Drug interactions are common and can be serious
  • Careful medication history is essential for patient safety

6Individual Variation in Drug Response

Genetic Factors

Pharmacogenomics examines how genetic variations affect drug metabolism and response, enabling personalized medicine approaches.

Key Polymorphisms:
  • CYP450 Variants: Slow metabolizers at increased risk of toxicity; fast metabolizers may need higher doses
  • TPMT Deficiency: Affects thiopurine metabolism, critical for leukemia and transplant patients
  • HLA Variants: Associated with severe cutaneous adverse reactions to drugs like abacavir and allopurinol

Non-Genetic Factors

Factor Effect on Drug Response
Age Elderly: reduced renal function, altered metabolism; Pediatric: immature enzyme systems
Body Weight Affects volume of distribution and clearance; dosing adjustments needed
Sex Differences in metabolism, body composition, and hormone levels affect drug action
Disease State Renal/hepatic disease alters pharmacokinetics; inflammatory conditions may alter pharmacodynamics
Pregnancy Increased plasma volume, altered metabolism; concern for fetal effects

Environmental Factors

Diet: Grapefruit juice inhibits CYP3A4, increasing levels of many drugs.

Smoking: Induces CYP1A2, reducing efficacy of many drugs including theophylline.

Alcohol: Can enhance CNS depression and impair metabolism of certain drugs.

✓ Key Points

  • Genetic variations significantly affect drug metabolism and response
  • Age, disease, and environmental factors alter pharmacokinetics and pharmacodynamics
  • Personalized medicine uses genetic and phenotypic information to optimize therapy

7Drug Development and Regulation

Drug Discovery Process

  1. Target Identification: Identify disease mechanism and molecular targets
  2. Compound Screening: Test thousands of compounds for activity
  3. Lead Optimization: Improve potency, selectivity, and pharmacokinetics
  4. Preclinical Testing: Laboratory and animal studies for safety and efficacy

Clinical Trials

Phase Population Objective
Phase I 20-100 healthy volunteers Safety, dosage, pharmacokinetics
Phase II 100-500 patient volunteers Efficacy, side effects, optimal dose
Phase III 1,000-5,000 patient volunteers Efficacy, adverse reactions, comparison with standard treatments
Phase IV Post-marketing surveillance Monitor long-term effects and additional uses

Regulatory Approval

Regulatory agencies (FDA in USA, EMA in Europe) review clinical trial data and manufacturing information before approving drugs for human use. Post-marketing surveillance continues to monitor drug safety after approval.

✓ Key Points

  • Drug development from discovery to approval takes 10-15 years on average
  • Clinical trials are essential for establishing safety and efficacy
  • Regulatory oversight protects public health

8Clinical Applications and Therapeutic Principles

Treatment Planning

Rational Therapeutics

  • Make accurate diagnosis before prescribing
  • Select drug with known efficacy for the condition
  • Know the pharmacokinetics and pharmacodynamics of the drug
  • Use lowest effective dose for shortest necessary duration
  • Be aware of potential drug interactions and contraindications

Dosing Strategies

Loading Dose: Initial higher dose to rapidly achieve therapeutic concentration (Loading Dose = Vd × Target Concentration)

Maintenance Dose: Regular doses to maintain therapeutic levels (Maintenance Dose = (Clearance × Target Concentration) / Bioavailability)

Adjustment Factors: Renal function, hepatic function, age, drug interactions, therapeutic drug monitoring

Monitoring Treatment Response

Therapeutic Drug Monitoring (TDM)

Blood level monitoring is essential for drugs with narrow therapeutic indices (e.g., digoxin, theophylline, aminoglycosides, cyclosporine) to ensure efficacy and safety.

Medication Safety

  • Always verify patient drug allergies and reactions
  • Check for drug-drug and drug-food interactions
  • Use standardized abbreviations and avoid error-prone abbreviations
  • Counsel patients on proper administration and adherence
  • Report adverse events to regulatory agencies

✓ Key Points

  • Rational therapeutics requires understanding of drug properties and patient factors
  • Dosing should be individualized based on pharmacokinetics and patient conditions
  • Monitoring improves efficacy and safety of pharmacotherapy
❓ Go to Quiz 🔬 Go to Exercises 🏠 Back to Home